대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제4장 갑상선분화암의 수술 후 병리학적 진단 및 병기 결정 2024
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신수진 | - |
dc.contributor.author | 나희영 | - |
dc.contributor.author | 강호철 | - |
dc.contributor.author | 김선욱 | - |
dc.contributor.author | 나동규 | - |
dc.contributor.author | 박영주 | - |
dc.contributor.author | 송영신 | - |
dc.contributor.author | 이은경 | - |
dc.contributor.author | 임동준 | - |
dc.contributor.author | 정윤재 | - |
dc.contributor.author | 정찬권 | - |
dc.date.accessioned | 2024-07-15T01:00:28Z | - |
dc.date.available | 2024-07-15T01:00:28Z | - |
dc.date.issued | 2024-05 | - |
dc.identifier.issn | 2384-3799 | - |
dc.identifier.issn | 2466-1899 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74745 | - |
dc.description.abstract | Postoperative pathological diagnosis of differentiated thyroid cancer (DTC) is important to confirm the diagnosis and predict the risk of recurrence and death. Further treatment plans, such as completion thyroidectomy, radioiodine remnant ablation, or external beam radiation therapy, are then opted for to reduce the predicted risk of recurrence or death. The World Health Organization has classified thyroid cancers into seven distinct categories based on the molecular profile and tumor cell origin. Our recommendation is applicable to differentiated follicular cell-derived carcinoma, the most common form of thyroid cancer, and cribriform morular thyroid carcinoma. Postoperative clinical and pathological staging is recommended for all patients with DTC to determine their prognosis and subsequent treatment decisions. In particular, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system is recommended for staging DTCs for disease mortality prediction and national cancer registries. The information in the pathology report, including histologic features of the tumor that are necessary for AJCC/UICC staging and recurrence prediction, can help assess the patient’s risk. | - |
dc.format.extent | 7 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한갑상선학회 | - |
dc.title | 대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제4장 갑상선분화암의 수술 후 병리학적 진단 및 병기 결정 2024 | - |
dc.title.alternative | Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 4. Pathological Diagnosis and Staging after Thyroidectomy 2024 | - |
dc.type | Article | - |
dc.identifier.doi | 10.11106/ijt.2024.17.1.61 | - |
dc.identifier.bibliographicCitation | International Journal of Thyroidology, v.17, no.1, pp 61 - 67 | - |
dc.identifier.kciid | ART003086068 | - |
dc.description.isOpenAccess | Y | - |
dc.citation.endPage | 67 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 61 | - |
dc.citation.title | International Journal of Thyroidology | - |
dc.citation.volume | 17 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Thyroid neoplasms | - |
dc.subject.keywordAuthor | Pathology | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Registries | - |
dc.subject.keywordAuthor | Korean Thyroid Association | - |
dc.subject.keywordAuthor | 갑상선종양 | - |
dc.subject.keywordAuthor | 병리학 | - |
dc.subject.keywordAuthor | 진단 | - |
dc.subject.keywordAuthor | 진료권고안 | - |
dc.subject.keywordAuthor | 예후 | - |
dc.subject.keywordAuthor | 등록 | - |
dc.subject.keywordAuthor | 대한갑상선학회 | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.